PremiumThe FlyGracell downgraded to Equal Weight from Overweight at Wells Fargo Gracell downgrade, Fusion upgrade: Wall Street’s top analyst calls Gracell price target raised to $10 from $7 at Wells Fargo PremiumMarket NewsM & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B M & A News: AstraZeneca (NASDAQ:AZN) to Acquire Gracell for $1.2B Gracell jumps 61% to $9.97 after AstraZeneca buyout agreement PremiumThe FlyGracell presents clinical data from FasTCAR-T GC012F Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call Stifel doubts FDA investigation is end for CAR T in autoimmune 
